William M Gallaher

18PUBLICATIONS
89CO-AUTHORS
Molecular targetsPredictive and prognostic markersTumour immunologyCancer geneticsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Feb 03, 2026
PI3K Inhibition in Combination with Tamoxifen in Patients with Metastatic HR+/HER2- Breast Cancer: Clinical and Circulating Tumor DNA Results.

Rosie A B Voorthuis, Mafalda Oliveira, Annelot G J van Rossum

|Sep 23, 2022
Application of Artificial Intelligence Techniques to Predict Risk of Recurrence of Breast Cancer: A Systematic Review.

Claudia Mazo, Claudia Aura, Arman Rahman

|Jul 14, 2022
Mapping the Immune Landscape in Metastatic Melanoma Reveals Localized Cell-Cell Interactions That Predict Immunotherapy Response.

Asier Antoranz, Yannick Van Herck, Maddalena M Bolognesi

|Feb 03, 2022
Emerging role for the Serum Response Factor (SRF) as a potential therapeutic target in cancer.

Haleema Azam, Lisa Pierro, Martina Reina

|Jan 21, 2022
Identifying the Steps Required to Effectively Implement Next-Generation Sequencing in Oncology at a National Level in Europe.

Denis Horgan, Giuseppe Curigliano, Olaf Rieß

|Dec 02, 2020
Inhibition of Serum Response Factor Improves Response to Enzalutamide in Prostate Cancer.

R William Watson, Haleema Azam, Claudia Aura

Pageof 3